Key result
Surgical embolectomy for massive PE is linked to similar mortality but ~86% less severe bleeding than thrombolysis.
Why the study?
The treatment of massive pulmonary embolism remains debated, with uncertainty regarding outcomes and quality of life between surgical embolectomy and thrombolytic therapy.
Does pulmonary surgical embolectomy improve early mortality and reduce bleeding complications compared to thrombolytic therapy in patients with massive pulmonary embolism?
Comparison
Pulmonary surgical embolectomy versus thrombolytic therapy
Design
Cohort study
Follow-up
Mean 63 ± 21 months
Authors
Loading...
May reduce severe bleeding with similar mortality in massive PE; leaves open optimal first-line strategy pending randomized trials.
Cohort (n=80)
No
Does pulmonary surgical embolectomy improve early mortality and reduce bleeding complications compared to thrombolytic therapy in patients with massive pulmonary embolism?
Absolute Event Rate: 3.6% vs 13.5%
Surgical embolectomy is a viable treatment option for massive pulmonary embolism, offering comparable early mortality and significantly fewer bleeding complications than thrombolytic therapy.
Aymard et al. (2012) conducted a cohort in Massive pulmonary embolism (n=80). Surgical embolectomy vs. Thrombolytic therapy was evaluated on Early mortality. Surgical embolectomy for massive pulmonary embolism had similar early mortality (3.6% vs 13.5%) but fewer severe bleeding complications (3.6% vs 26.5%, P=0.013) than thrombolytic therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: